- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE sees FDA clearance on Horizon
GE Medical Systems has won Food and Drug Administration 510(k)clearance for Signa Horizon, the Milwaukee vendor's new 1-teslaand 1.5-tesla MRI platforms. GE introduced Horizon at the RadiologicalSociety of North America meeting last year (SCAN 12/28/94).
GE Medical Systems has won Food and Drug Administration 510(k)clearance for Signa Horizon, the Milwaukee vendor's new 1-teslaand 1.5-tesla MRI platforms. GE introduced Horizon at the RadiologicalSociety of North America meeting last year (SCAN 12/28/94). Horizonfeatures a 60-cm patient bore and fast-scanning packages withactively shielded 23 millitesla/meter gradient coils. The scannersreceived clearance a few weeks after the conference.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
